The blood brain barrier is a physiological barrier to any molecule that might try to penetrate the brain. Being the most vital organ of the body, the brain has a unique filtering system that keeps it from external influence. This blood brain barrier is effective at blocking all but essential nutrients from the body.
While this keeps infections and maladies of the brain at bay, it also makes targeted drug delivery difficult. With the increasing awareness about neurological disorders, this technology is becoming more relevant and set to see increased demand over the forecast period of 2020 to 2030, states TMR.
The blood brain barrier technologies market is dominated by a number of players. This makes the market landscape fragmented. Some of these players are:
All these market players are looking to expand production of innovations that would serve the need for blood brain barrier technologies.
North America currently leads in the blood brain barrier technologies market owing to a robust healthcare infrastructure that quickly adapts to innovations. An ageing population will bring more brain diseases to the fore, creating need for targeted therapy. The Asia Pacific region (APAC) is set to register steady growth in this market in the future given the rising awareness among its people about cognitive diseases and a growing healthcare sector.